Shree Ganesh Remedies IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 8.55 Cr. The company is based in Ankleshwar and caters to Chemical sector. Fedex Securities is the merchant banker of Shree Ganesh Remedies IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th August 2017.
Shree Ganesh Remedies IPO posted revenues of ₹ 20.32 crores and PAT of ₹ 2.61 crores in FY17 on annualised basis.Financial results of Shree Ganesh Remedies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Mar-17 | FY16 | FY15 | FY14 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 21.16 | 15.66 | 15.24 | 14.51 | |
Net Worth | 16.53 | 13.98 | 12.90 | 11.65 | |
Total Debt | [●] | [●] | 0.02 | 0.05 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
19.85
19.85 |
15.52 | 16.49 | 18.34 | |
EBITDA
EBITDA on annualised basis |
4.50
4.50 |
2.27 | 2.65 | 5.41 | |
PAT
PAT on annualised basis |
2.61
2.61 |
1.08 | 1.27 | 3.21 |
Shree Ganesh Remedies IPO PAT Margin is 13.15 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Shree Ganesh Remedies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Mar-17 | FY16 | FY15 | FY14 |
---|---|---|---|---|
EBITDA Margin (%) | 22.67 | 14.63 | 16.07 | 29.50 |
PAT Margin (%) | 13.15 | 6.96 | 7.70 | 17.50 |
EPS (₹) | 13.50 | 29.25 | 11.60 | 9.86 |
ROE (%) | 15.79 | 7.73 | 9.84 | 27.55 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 12.33 | 6.90 | 8.33 | 22.12 |
Debt to Equity | [●] | [●] | 0.00 | 0.00 |
The market Capitalisation of Shree Ganesh Remedies IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Shree Ganesh Remedies IPO prospectus highlights an Return on Equity (ROE) of 15.79 % , Return on Assets (ROA) of 12.33 %, and an EBITDA Margin of 22.67 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Shree Ganesh Remedies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Shree Ganesh Remedies IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Shree Ganesh Remedies IPO has a Price-to-Earnings (PE) ratio of 12.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Shree Ganesh Remedies IPO reported revenue of ₹ 20.32 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Shree Ganesh Remedies IPO provide insights into sales growth, market demand, and business scalability.
Shree Ganesh Remedies recorded an EBITDA of ₹ 4.50 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Shree Ganesh Remedies Profit After Tax (PAT) is ₹ 2.61 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Shree Ganesh Remedies operates in Chemical and Manufactures Chemicals Used In Pharma. The Issue is listed on BSE SME in Oct, 2017. Shree Ganesh Remedies IPO size was 8.55 with Issue price of 36.00 .
Merchant Banker(s) of Shree Ganesh Remedies IPO: Fedex Securities Private Limited
Shree Ganesh Remedies IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Shree Ganesh Remedies IPO listed at a listing price of 33.00 against the offer price of 36.00.
The current market price of Shree Ganesh Remedies is 599.45.
Why Us?